Someone told me about this study earlier today. This was something I've mentioned previously, and the FDA has even brought up concerns that this would happen and mentioned that Merck had to collect data to see if this would happen. The committee was really concerned about this issue to the point that a few recommended patients taking Molnupiravir should isolate from their family in case of mutations...